| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/12/2008 | WO2008106983A1 A method for non-therapeutic or therapeutic photodynamic skin treatment |
| 09/12/2008 | WO2008106979A2 Pharmaceutical compositions comprising flavonoids and xylitol |
| 09/12/2008 | WO2008106966A1 A method for non-therapeutic or therapeutic photodynamic skin treatment |
| 09/12/2008 | WO2008106901A1 A pharmaceutical composition with atorvastatin active ingredient |
| 09/12/2008 | WO2008106863A1 The use of iridoids in the manufacture of the medicine for promoting nerve cell proliferation and differentiation |
| 09/12/2008 | WO2008106860A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
| 09/12/2008 | WO2008106821A1 A chinese medicine composition and the extract of worms thereof and their preparation |
| 09/12/2008 | WO2008106803A1 Double-stranded locked nucleic acid compositions |
| 09/12/2008 | WO2008106796A1 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity |
| 09/12/2008 | WO2008106781A1 Treatment of squamous cell carcinoma with hsp27 antisense oligonucleotides and radiotherapy |
| 09/12/2008 | WO2008106779A1 Gastrin compound for diabetes treatment |
| 09/12/2008 | WO2008106775A1 Combination treatment for diabetes using an egf receptor ligand and a gastrin compound |
| 09/12/2008 | WO2008106772A1 Phospholipid compositions with improved bioavailability and methods for their use |
| 09/12/2008 | WO2008106763A1 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| 09/12/2008 | WO2008106751A1 Paromomycin supplemented feedingstuffs for poultry species and use thereof for prophylaxis of histomoniasis, reduction of the horizontal spreading of histomoniasis, and for improved weight gain and feed conversion |
| 09/12/2008 | WO2008106738A1 Compositions for the treatment of sexual dysfunction |
| 09/12/2008 | WO2008106730A1 Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents |
| 09/12/2008 | WO2008106724A1 Transplants |
| 09/12/2008 | WO2008106721A1 Compositions and methods for delivery of anti-cancer agents |
| 09/12/2008 | WO2008106715A1 Oxazinyl isoflavonoid compounds, medicaments and use |
| 09/12/2008 | WO2008106702A1 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue |
| 09/12/2008 | WO2008091957A3 Pharmaceutical compositions containing famotidine and ibuprofen and having improved content uniformity |
| 09/12/2008 | WO2008089933A3 Benzoquinazole derivatives |
| 09/12/2008 | WO2008089463A3 Substituted 1,3-dioxanes and their uses |
| 09/12/2008 | WO2008089462A3 Substituted 1,3-dioxanes and their uses |
| 09/12/2008 | WO2008089453A3 Inhibitors of d-amino acid oxidase |
| 09/12/2008 | WO2008089105A3 Antiviral nucleoside analogs |
| 09/12/2008 | WO2008087560A3 Thiazolidine derivatives and methods for the preparation thereof |
| 09/12/2008 | WO2008087140A3 Liquid formulations containing a carotinoid |
| 09/12/2008 | WO2008086096A8 Myocardial perfusion imaging |
| 09/12/2008 | WO2008085492A3 Methods and compositions for modulating bk channel activity and vasodilation |
| 09/12/2008 | WO2008085038A3 Method of treating or preventing infertility in a female mammal and pharmaceutical kit for use in such method |
| 09/12/2008 | WO2008080413A3 An antisense oligonucleotide, pharmaceutical composition and a method for downregulation of peripheral neuronal nitric oxide synthase and mu-opioid receptors and use of an antisense oligonucleotide for drug production |
| 09/12/2008 | WO2008079257A3 Methods for treating nasal congestion in pediatric patients |
| 09/12/2008 | WO2008077127A3 Use of modafinil to treat restless leg syndrome |
| 09/12/2008 | WO2008076916A3 Thallium-sensitive agents and methods of using the same |
| 09/12/2008 | WO2008076443A3 Combination therapy for treating hepatitis c infections |
| 09/12/2008 | WO2008076245A3 Nitroderivatives as angiotensin ii receptor antagonists |
| 09/12/2008 | WO2008074935A3 Biologically active compositions, methods for producing the same and biological applications |
| 09/12/2008 | WO2008074824A3 Isoquinolinecarboxamides as inhibitors of stearoyl-coa desaturase (scd) |
| 09/12/2008 | WO2008073451A3 Benzoimidazole derivatives as sirtuin (sir) modulating compounds |
| 09/12/2008 | WO2008072952A3 Anti-inflammatory compounds containing compositions for treatment of cancer |
| 09/12/2008 | WO2008071650A3 Novel compounds useful for the treatment of degenerative & inflammatory diseases |
| 09/12/2008 | WO2008070507A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/12/2008 | WO2008070016A3 Inhibitors of akt activity |
| 09/12/2008 | WO2008069941A3 Modified release ibuprofen solid oral dosage form |
| 09/12/2008 | WO2008067002A8 Azole nucleosides and use as inhibitors of rna and dna varial polymerases |
| 09/12/2008 | WO2008065107A8 Storage stable tablets based on benzimidazole derivatives coated with a gastro-resistant film |
| 09/12/2008 | WO2008063609A3 Diimide-based semiconductor materials and methods of preparing and using the same |
| 09/12/2008 | WO2008062324A3 Compositions comprising nicotinamide and wakame extract having skin anti-aging properties |
| 09/12/2008 | WO2008060964A3 Unit dosage package and methods for administering weight loss medications |
| 09/12/2008 | WO2008060934A3 Formulations of tetrahydropyridine antiplatelet agents for parenteral or oral administration |
| 09/12/2008 | WO2008057994A3 Pyrrolotriazine kinase inhibitors |
| 09/12/2008 | WO2008049997A3 Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 09/12/2008 | WO2008049073A3 Compositions for the treatment of inflammation in the brain and other tissues |
| 09/12/2008 | WO2008046902A3 Compounds and methods for the modulation of toll-like receptor function |
| 09/12/2008 | WO2008043857A3 Novel method of treatment of male sub-fertility |
| 09/12/2008 | WO2008037224A3 Controlled release dosage form containing lercanidipine and a performance enhancing acid |
| 09/12/2008 | WO2008030532A3 Substituted oxazole ketone modulators of fatty acid amide hydrolase |
| 09/12/2008 | WO2008027796A3 Compositions and methods for treating or preventing glaucoma or progression thereof |
| 09/12/2008 | WO2008020056A3 Aerosol formulation containing beta agonists and steroids |
| 09/12/2008 | WO2008019025A3 Isoform-selective hdac inhibitors |
| 09/12/2008 | WO2008012227A8 Pyrazoles as glucokinase activators |
| 09/12/2008 | WO2008011588A3 Glycoconjugates of phosphoramidate alkylators for treatment of cancer |
| 09/12/2008 | WO2008002567A3 Methods of treating conditions by sustained release administration of benzimidazole derivatives |
| 09/12/2008 | WO2007150002A3 PRODRUGS OF 5-AMINO-3-(3'-DEOXY-β-D-RIBOFURANOSYL)-THIAZOLO[4,5-d] PYRIMIDIN-2,7-DIONE |
| 09/12/2008 | WO2007144345A3 Cholecystokinin-1 (cck1) receptor antagonists in the treatment of gastrointestinal and related disorders |
| 09/12/2008 | WO2007137168A3 Bridged aryl piperazines derivatives useful for the treatment of cns, gi-urinary and reproductive disorders |
| 09/12/2008 | WO2007134678A3 Triazole derivatives ii |
| 09/12/2008 | WO2007117556A3 Pharmaceutical compositions and uses thereof |
| 09/12/2008 | WO2007117399A3 Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor |
| 09/12/2008 | WO2007114843A3 Light activated antiviral materials and devices and methods for decontaminating virus infected environments |
| 09/12/2008 | WO2007113309A3 Compounds which inhibit the glycine transporter and uses thereof |
| 09/12/2008 | WO2007107594A3 Six-membered heterocycle substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 09/12/2008 | WO2007103134A3 Prolongation of survival of an allograft by inhibiting complement activity |
| 09/12/2008 | WO2007073176A3 Composition comprising a polyunsaturated fatty acid for improving membrane composition |
| 09/12/2008 | WO2006116148A3 (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse |
| 09/12/2008 | WO2006065968A8 The uses of estrogen beta agonists to treat cognitive diseases |
| 09/12/2008 | WO2004078116A9 P38 inhibitors and methods of use thereof |
| 09/12/2008 | CA2717162A1 Transplants |
| 09/12/2008 | CA2707757A1 Process for the preparation of quaternary n-alkyl morphinan alkaloid salts |
| 09/12/2008 | CA2696232A1 Protein tyrosine phosphatase 1b inhibitor, preparation methods and uses thereof |
| 09/12/2008 | CA2683016A1 9h- purine derivatives and their use in the treatment of proliferative diseases |
| 09/12/2008 | CA2682756A1 New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives |
| 09/12/2008 | CA2680415A1 Neuraminic acid derivatives useful in the treatment of influenza |
| 09/12/2008 | CA2680324A1 Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds |
| 09/12/2008 | CA2680312A1 Metalloprotease inhibitors containing a heterocyclic moiety |
| 09/12/2008 | CA2680212A1 Substituted phenoxy aminothiazolones as estrogen related receptor-.alpha. modulators |
| 09/12/2008 | CA2680186A1 Heterocyclic cyclopamine analogs and methods of use thereof |
| 09/12/2008 | CA2680179A1 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient |
| 09/12/2008 | CA2680177A1 Metalloprotease inhibitors containing a heterocyclic moiety |
| 09/12/2008 | CA2680173A1 Metalloprotease inhibitors containing a heterocyclic moiety |
| 09/12/2008 | CA2680161A1 Pharmaceutical composition |
| 09/12/2008 | CA2680139A1 New methylenebisphenyl compounds useful in the treatment of inflammation |
| 09/12/2008 | CA2680134A1 Restrictive agonist of toll-like receptor 3 (tlr3) |
| 09/12/2008 | CA2680129A1 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell |
| 09/12/2008 | CA2680125A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2-receptor modulators |
| 09/12/2008 | CA2680120A1 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives |
| 09/12/2008 | CA2680119A1 Steroids derivatives as selective progesterone receptor modulators |
| 09/12/2008 | CA2680109A1 Indazoles used to treat estrogen receptor beta mediated disorders |